Epstein Secrets

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 134.01 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

ccrued Interest Yield US Fixed Income ALLY FINANCIAL INC 22.40 8 1/2% PFD 02005N-30-8 NA /CAA HARTFORD FINL SVCS GRP PFD 7 7/8% 416518-50-4 AMERICAN CAPITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 02503Y-AF-0 B /NA ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA2 HCA INC

sition. Please contact your J.P. Morgan team for additional information. ** Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC FACEBOOK INC-A 04033A-10-0 ARIA 146.59 09062X-10-3 BIIB 18.06 30303M-10-2 FB GS CONT BUFF EQ SPX 7/9/13 80% CONTIN BARRIER- 10.5%CPN 15% CAP

8/22 8/23 8/23 8/27 8/27 8/27 Corporate Interest FX Fwd Contract FX Fwd Contract Corporate Interest Corporate Interest Corporate Interest AMERICAN CAPITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 (ID: 02503Y-AF-0) SETTLE FORWARD CURRENCY CONTRACT BUY MXN SELL USD CONTRACT RATE : 13.268700000 TRADE 7/19/12 V

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 130.75 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

ost Unrealized Gain/Loss Est. Annual Income Accrued Interest Yield US Fixed Income ALLY FINANCIAL INC 21.80 8 1/2% PFD 02005N-30-8 NA /CAA AMERICAN CAPITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 02503Y-AF-0 B /NA ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA2 HCA INC

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 126.00 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

ost Unrealized Gain/Loss Est. Annual Income Accrued Interest Yield US Fixed Income ALLY FINANCIAL INC 21.70 8 1/2% PFD 02005N-30-8 NA /CAA AMERICAN CAPITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 02503Y-AF-0 B /NA ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA2 FORD MOT

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 144.38 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

1 1,099,726.08 $1,099,726.09 (37,038.94) ($37,038.94) $0.00 0.00% US Fixed Income ALLY FINANCIAL INC 22.95 8 1/2% PFD 02005N-30-8 NA /CAA AMERICAN CAPITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 02503Y-AF-0 B /NA ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC

e position. Please contact your J.P. Morgan team for additional information. Equity Detail Price US Large Cap Equity ARIAD PHARMACEUTICALS INC BIOGEN IDEC INC 04033A-10-0 ARIA 145.83 09062X-10-3 BIIB DB CONT BUFF EQ MS 08/07/12 25% CONTIN BARRIER- 13%CPN 30% CAP INITIAL LEVEL-07/15/11 MS:21.09 2515A

1 1,099,726.08 $1,099,726.09 (68,441.01) ($68,441.01) $0.00 0.00% US Fixed Income ALLY FINANCIAL INC 23.24 8 1/2% PFD 02005N-30-8 NA /CAA AMERICAN CAPITAL LTD 8.96% DEC 31 2013 DTD 06/28/2010 02503Y-AF-0 B /NR ROYAL BANK SCOTLAND GRP PLC 5.05% JAN 08 2015 DTD 12/08/2004 780097-AP-6 BB+ /BA3 HCA INC